Colospa is a prescription medication that contains the active ingredient mebeverine. It belongs to the digestive health category of drugs and is marketed as a pill with a strength of 135 mg. In Hong Kong, Colospa is regulated by the Department of Health and is available only with a physician’s prescription. The medication is commonly used to relieve cramps and spasms of the gastrointestinal (GI) tract.
Mebeverine is an antispasmodic agent. It acts directly on the smooth muscle cells lining the intestines, helping them relax without affecting the normal motility of the GI tract. The drug interferes with calcium influx into the muscle cells, which reduces the strength and frequency of painful intestinal contractions. Clinical effects typically begin within 30 minutes of ingestion, reach a peak around 1-2 hours, and last for approximately 4-6 hours. Because mebeverine is poorly absorbed from the gut, its systemic exposure is low, which limits central nervous system side effects.
Colospa is approved in Hong Kong for the symptomatic treatment of irritable bowel syndrome (IBS) and other functional bowel disorders characterized by abdominal pain, cramping, and altered bowel habits. The medication helps alleviate the spasmodic component of these conditions, improving comfort and quality of life for many adult patients.
These reactions are generally mild and transient. If they persist or worsen, patients should contact their healthcare provider.
Any of these symptoms require immediate medical attention.
Patients should disclose all prescription medicines, over-the-counter products, herbal supplements, and dietary supplements to their prescriber before starting Colospa.
Routine monitoring for patients on Colospa includes:
Regular follow-up ensures that the therapeutic benefit continues and that any emerging safety concerns are addressed promptly.
This article provides educational information about Colospa and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Colospa is primarily indicated for intestinal spasms, not for constipation. While it may reduce painful cramping, it does not promote bowel movements and could potentially worsen constipation in some individuals. Discuss alternative treatments with your healthcare provider.
Severe dizziness could indicate an adverse reaction or an interaction with another medication. Stop driving or operating machinery and contact your prescriber promptly to evaluate whether a dosage adjustment or a different therapy is needed.
Both contain the same active ingredient, mebeverine 135 mg. Differences may exist in inactive ingredients, tablet shape, or imprint code, which can affect tolerability for patients with specific allergies. Always verify the formulation with your pharmacist.
Yes, Colospa can be taken before travel. However, maintain adequate hydration and consider taking the dose with a small snack to reduce the risk of nausea or abdominal discomfort at altitude.
Mebeverine does not have a known chemical interaction with antacids, so they can usually be taken together. Nonetheless, separate the doses by at least 30 minutes to avoid any potential absorption interference.
Colospa 135 mg tablets are typically round, white, and bear a distinct imprint code (e.g., “C135”) on one side. Counterfeit products may differ in color, shape, or lack an imprint, so verify with a pharmacist when in doubt.
Mebeverine is not a controlled substance and is not included in standard workplace or athletic drug-screening panels. It should not affect routine drug-testing results.
Both aim to relieve abdominal cramps, but mebeverine (Colospa) works by directly relaxing intestinal smooth muscle, while peppermint oil exerts a topical antispasmodic effect after enteric coating. Clinical choices depend on individual response and tolerance.
No specific food restrictions exist, but high-fat meals may delay gastrointestinal transit, potentially altering symptom perception. Keeping a balanced diet and noting any foods that trigger discomfort can help optimize therapy.
The tablet is formulated for whole-pill ingestion to ensure consistent absorption. Splitting or crushing may affect drug release and efficacy. Consult your prescriber for alternative dosing options if a lower dose is required.
